MLN1202

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MLN1202, covering 2008-07-15 to 2016-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Single Subcutaneous Dose Study of MLN1202 [Phase 1]